NEwsletters
January 2023
Peptides are a promising class of therapeutics with unique properties. They share some advantages of proteins, such as their high …Read more
October 2022
Our CSO, Dr. Quentin Perron and VP, Head of BD- EU, RoW Dr. Sree Vadlamudi presented a webinar on ‘Makya™: Iktos technology platform …Read more
August 2022
Take a tour of our new website and explore our AI-driven generative modeling technology platform …Read more
April 2022
We are very pleased to announce our 2nd Annual ‘AI for De Novo Drug Design’ Conference to be held virtually on May 3 and 4, 2022…Read more
January 2022
Our research paper on ‘Integrating synthetic accessibility with AI-based generative drug design’ was recently published by ChemRxiv…Read more
October 2021
We presented a webinar on ‘Spaya: Artificial Intelligence to discover and prioritise synthetic routes’. If you missed…Read more